Nephron

Nephron Pharmaceuticals' generic products help individuals with respiratory conditions. Some of our products relax the muscles around the airways, while others prevent muscle constriction, both aiding individuals in breathing more easily. The company is a global leader in the manufacturing of generic respiratory medications. The FDA approved our first generic respiratory drug in 1997, and since then, we have been committed to bringing safe, effective, and affordable medications to patients in need. Our mission to improve patient outcomes drives our commitment to innovation, quality, and service. We have invested in state-of-the-art facilities and industry-leading technologies to expand our ability to assist patients. We have established an outsourcing division to support healthcare institutions requiring 503B compounded medications, typically during drug shortages. Our new facility also enables us to develop and bring to market new ophthalmic and injectable drugs. Since our inception, we have led the industry in safety and quality. Just a few years after launching our first drug, we became a market leader in safety practices related to drug packaging and barcoding. This approach has now become standard practice in U.S. hospitals. Today, we take pride in using fully automated manufacturing, packaging, and distribution systems to minimize contamination.